American Board of Psychiatry and Neurology

The board that has certified psychiatrists and neurologists since 1934, setting the standard for the physicians who treat the mind and the nervous system.

  • www.abpn.com
  • Citadel
  • Deerfield, IL
  • Professional and scientific society
  • Read from public sources, Jul 2026
47named by peers

Financial profile

American Board of Psychiatry and Neurology · EIN 41-0654864 · 501(c)(6)

Fiscal yearTotal revenueContributionsProgram servicesTotal expensesNet assetsYear end
FY2023$26,435,371$0$21,442,018$18,322,754$188,754,574Dec 2023
FY2022$31,571,605$0$27,830,169$20,734,250$169,554,844Dec 2022
FY2021$29,385,701$0$18,251,101$17,172,022$178,123,060Dec 2021
FY2020$23,105,643$0$18,364,900$19,765,957$157,790,684Dec 2020
FY2019$24,765,811$0$20,555,130$13,914,071$146,405,939Dec 2019
FY2018$24,675,818$0$20,335,737$14,043,178$122,470,594Dec 2018

Figures exactly as reported. A blank cell was blank on the form. The fiscal year links to the filing.

Something wrong here? Tell us what we missed.

Peer societies

Five societies American Board of Psychiatry and Neurology is read alongside.

Who backs ABPN

No public supporter list found as of September 2026.

Something wrong here? Tell us what we missed.

Who backs American Board of Psychiatry and Neurology's peers, but not American Board of Psychiatry and Neurology

Companies named publicly by at least one of American Board of Psychiatry and Neurology's five peer societies, and not found in American Board of Psychiatry and Neurology's reviewed public records.

CompanyAANPeers
AbbvieNamed1 of 1
AcadiaNamed1 of 1
AlexionNamed1 of 1
AlkermesNamed1 of 1
Alnylam Pharmaceuticals, Inc.Named1 of 1
AmgenNamed1 of 1
Amneal Specialty, a division of Amneal Pharmaceuticals LLCNamed1 of 1
Annexon BiosciencesNamed1 of 1
ArgenexNamed1 of 1
AstraZenecaNamed1 of 1
Avidity BiosciencesNamed1 of 1
Bayer logoNamed1 of 1
BiogenNamed1 of 1
Bristol Myers SquibbNamed1 of 1
C2N DiagnosticsNamed1 of 1
Cognito TherapeuticsNamed1 of 1
Dianthus TherapeuticsNamed1 of 1
EisaiNamed1 of 1
GenentechNamed1 of 1
Harmony Biosciences logoNamed1 of 1
ImmunovantNamed1 of 1
InsightecNamed1 of 1
Ionis PharmaceuticalsNamed1 of 1
Ispen Biopharmaceuticals logoNamed1 of 1
ITF TherapeuticsNamed1 of 1
Johnson & JohnsonNamed1 of 1
Kyverna TherapeuticsNamed1 of 1
LantheusNamed1 of 1
LillyNamed1 of 1
LundbeckNamed1 of 1
Neurocrine BiosciencesNamed1 of 1
NovartisNamed1 of 1
Novo NordiskNamed1 of 1
OctapharmaNamed1 of 1
PfizerNamed1 of 1
Praxis Precision Medicines, Inc.Named1 of 1
RocheNamed1 of 1
SandozNamed1 of 1
SanofiNamed1 of 1
SpringWorksNamed1 of 1
Stoke TherapeuticsNamed1 of 1
Supernus_250x158_2022.pngNamed1 of 1
TakedaNamed1 of 1
TG Therapeutics, IncNamed1 of 1
UCBNamed1 of 1
Vor BiopharmaNamed1 of 1
Xenon PharmaceuticalsNamed1 of 1

Something wrong here? Tell us what we missed.

The outside view

The board that has certified psychiatrists and neurologists since 1934, setting the standard for the physicians who treat the mind and the nervous system.

  • Authority
  • Preserve
  • Outward
  • Operational

Their shape

The Citadel

Led from the center, built to endure.

The Citadel runs on clarity and decisiveness, its direction held by a strong center the whole organization moves behind. Its gift is speed and coherence, its challenge is leaning too heavily on the few at the middle.

Also reads toward The Republic and The Guild.

Strengths

→Decisions are clear and rarely second-guessed.
→Members trust that the institution will still be standing tomorrow.
→Strong operations keep the core running without drama.

Not an official page of American Board of Psychiatry and Neurology. Sociogene does not consult. Everything here comes from public sources, dated and linked. Something wrong here? Tell us what we missed.